Chinese and Russian manufacturers are seeing growing appetite from foreign buyers for their Covid-19 vaccines as the international scramble for jabs intensifies, despite lingering concerns over incomplete trial data and the rigour of domestic approval processes.
隨著各國對新冠疫苗爭奪加劇，中國和俄羅斯製造商看到外國買家對其新冠疫苗的興趣越來越大，儘管外界對試驗數據不完整和國內審批程式嚴謹程度的擔憂揮之不去。
您已閱讀4%（336字），剩餘96%（8134字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。